Benralizumab is an immunomodulator used to treat severe asthma. It works by inhibiting interleukin-5, reducing eosinophil levels and inflammation in the airways. Benralizumab is effective in managing asthma symptoms. In summary, it plays a vital role in asthma management.
Benralizumab binds to the IL-5 receptor, inhibiting eosinophil activation and survival.